Evidence map›Paper›PMID 23873932›Full record

ArticleThe Journal of biological chemistry2013

Nuclear factor κB2 p52 protein has a role in antiviral immunity through IκB kinase epsilon-dependent induction of Sp1 protein and interleukin 15.

Sarah L Doyle, Kari Ann Shirey, Anne F McGettrick, Elaine F Kenny, Susan Carpenter, Brian E Caffrey, Siobhan Gargan, Susan R Quinn, Jorge H Caamaño, Paul Moynagh and 2 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Manipulation of Non-canonical NF-κB Signaling by Non-oncogenic Viruses.Archivum immunologiae et therapiae experimentalis · 2019
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 3 countries.

Sarah L DoyleFrom the Immunology Research Centre, Trinity Biomedical Sciences Institute, School of Biochemistry and Immunology, Trinity College Dublin, Dublin 2, Ireland,. Electronic address: Sarah.Doyle@tcd.ie.
Kari Ann Shireythe Department of Microbiology and Immunology, University of Maryland, Baltimore, School of Medicine, Baltimore, Maryland 21201.
Anne F McGettrickFrom the Immunology Research Centre, Trinity Biomedical Sciences Institute, School of Biochemistry and Immunology, Trinity College Dublin, Dublin 2, Ireland.
Elaine F KennyFrom the Immunology Research Centre, Trinity Biomedical Sciences Institute, School of Biochemistry and Immunology, Trinity College Dublin, Dublin 2, Ireland.
Susan CarpenterFrom the Immunology Research Centre, Trinity Biomedical Sciences Institute, School of Biochemistry and Immunology, Trinity College Dublin, Dublin 2, Ireland.
Brian E Caffreythe Smurfit Institute of Genetics, Trinity College Dublin, Dublin 2, Ireland.
Siobhan Garganthe Institute of Immunology, Department of Biology, National University of Ireland Maynooth, Maynooth, County Kildare, Ireland, and.
Susan R QuinnFrom the Immunology Research Centre, Trinity Biomedical Sciences Institute, School of Biochemistry and Immunology, Trinity College Dublin, Dublin 2, Ireland.
Jorge H Caamañothe Institute for BioMedical Research-Medical Research Council (IBR-MRC) Centre for Immune Regulation, College of Medicine and Dental Sciences, University of Birmingham, Birmingham B15 2TT, United Kingdom.
Paul Moynaghthe Institute of Immunology, Department of Biology, National University of Ireland Maynooth, Maynooth, County Kildare, Ireland, and.
Stefanie N Vogelthe Department of Microbiology and Immunology, University of Maryland, Baltimore, School of Medicine, Baltimore, Maryland 21201.
Luke A O'NeillFrom the Immunology Research Centre, Trinity Biomedical Sciences Institute, School of Biochemistry and Immunology, Trinity College Dublin, Dublin 2, Ireland.
Trinity College Dublin · IENational University of Ireland, Maynooth · IEUniversity of Maryland, Baltimore · USMedical Research Council · GB

Funding

DIFFERENTIATIVE SIGNALS FOR MACROPHAGE ACTIVATIONR37AI018797 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI VOGEL, STEFANIE N. · 2000 to 2009
$5.3M
DIFFERENTIATIVE SIGNALS FOR MACROPHANGE ACTIVATIONR01AI018797 · NIAID · U.S. UNIFORMED SERVICES UNIV OF HLTH SCI · PI VOGEL, STEFANIE N. · 1985 to 2014
$3.8M
Differentiative Signals for Macrophage ActivationR56AI018797 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI VOGEL, STEFANIE N. · 2015 to 2015
$506k
Biotechnology and Biological Sciences Research Council BB/D018234/1NIAID NIH HHS AI18797NIAID NIH HHS R01 AI018797NIAID NIH HHS R37 AI018797NIAID NIH HHS R56 AI018797
6 · The paper itself

Abstract

In this study we describe a previously unreported function for NFκB2, an NFκB family transcription factor, in antiviral immunity. NFκB2 is induced in response to poly(I:C), a mimic of viral dsRNA. Poly(I:C), acting via TLR3, induces p52-dependent transactivation of a reporter gene in a manner that requires the kinase activity of IκB kinase ε (IKKε) and the transactivating potential of RelA/p65. We identify a novel NFκB2 binding site in the promoter of the transcription factor Sp1 that is required for Sp1 gene transcription activated by poly(I:C). We show that Sp1 is required for IL-15 induction by both poly(I:C) and respiratory syncytial virus, a response that also requires NFκB2 and IKKε. Our study identifies NFκB2 as a target for IKKε in antiviral immunity and describes, for the first time, a role for NFκB2 in the regulation of gene expression in response to viral infection.

Indexed as

AnimalsGene Expression RegulationHEK293 CellsHumansI-kappa B KinaseInterferon InducersInterleukin-15MiceMice, KnockoutNF-kappa B p52 SubunitPoly I-CRespiratory Syncytial VirusesRespiratory Syncytial Virus InfectionsResponse ElementsSp1 Transcription FactorToll-Like Receptor 3I-kappa B KinaseIL15 protein, humanInterferon InducersInterleukin-15NF-kappa B p52 SubunitNFKB2 protein, humanNfkb2 protein, mousePoly I-CRELA protein, humanRela protein, mouseSp1 Transcription FactorTLR3 protein, humanTLR3 protein, mouseToll-Like Receptor 3Transcription Factor RelACytokine InductionGene RegulationInnate ImmunityMolecular BiologyNF-κBSignal TransductionSp1Toll-like Receptor (TLR)TranscriptionViral Immunology

Identifiers

PMID23873932
PMCPMC3757171
OpenAlexW2057274347

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.